CGNH
vs
S&P 500
CGNH
S&P 500
Over the past 12 months, CGNH has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +15% growth.
Stocks Performance
CGNH vs S&P 500
Performance Gap
CGNH vs S&P 500
Performance By Year
CGNH vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
CardioGenics Holdings Inc
Glance View
CardioGenics Holdings, Inc. is a biotechnology company, which engages in the business of development and commercialization of diagnostic test products to the In Vitro Diagnostics testing market. The company is headquartered in Boca Raton, Florida. The company went IPO on 2004-06-09. The firm has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.
